Skip to main content
. 2024 Mar 4;13(3):101–109. doi: 10.1302/2046-3758.133.BJR-2023-0038.R2

Table I.

Halicin remains active against Staphylococcus aureus-Xen36 biofilms grown on orthopaedically relevant substrates. Minimal biofilm eradication concentrations from colony-forming unit assays are reported as fold change versus the planktonic minimal inhibitory concentrations, which we previously reported for this strain of S. aureus.18

Substrate Less mature 24-hour biofilms MBECs
(fold change vs MIC)
More mature 7-day biofilms MBECs
(fold change vs MIC)
Halicin Vancomycin Halicin Vancomycin
Ti6Al4V 10× MIC 100× MIC 20× MIC 400× MIC
Cobalt-chrome 10× MIC 200× MIC 10× MIC 100× MIC
UHMWPE 10× MIC 100× MIC 40× MIC 200× MIC
Muscle 40× MIC 50× MIC 40× MIC 100× MIC
Bone 40× MIC 100× MIC 40× MIC 200× MIC

p-values determined by Mann-Whitney U test were < 0.01, comparing MBECS for halicin to MBECs for vancomycin for both 24-hour and seven-day biofilms.

MBEC, minimum biofilm eradication concentration; MIC, minimal inhibitory concentration; UHMWPE, ultra-high molecular weight polyethylene.